JESSNER LYMPHOCYTIC INFILTRATE POST COVID VACCINATION

2021 ◽  
pp. 48-49
Author(s):  
Kammari Divya ◽  
Kakarla Sandhya Rani

Jessner-Kanof lymphocytic inltrate is a rare benign chronic T cell inltrative disease characterized by multiple tumid erythematous papules,plaques and nodules predominantly on sun exposed sites like face, neck and upper back. Etiology of Jessner lymphocytic inltrate is unknown but autoimmunity, Borrelia burgdorferi infection may have a possible role. There is a case report of Jessner lymphocytic inltrate after third dose of bee venom immunotherapy in hymenoptera venom anaphylaxis. Here,we report a case of 27 year married female who presented with multiple erythematous plaques and few nodules on face ,neck and upper back after 2 days of second dose of covishield vaccine. Clinical and histopathological correlation conrmed the diagnosis of Jessner-Kanof lymphocytic inltrate. Skin biopsy revealed dense perivascular and periadnexal lymphocytic inltrates in the dermis. Dermatological manifestations with covid vaccines are few in clinical volunteers but have been increasing since mass vaccination has started. A few side effects like urticaria , erythema and edema at injection site, pityriasis rosea, covid toes, systemic lupus erythematosus,rheumatoid arthritis have been reported after covid vaccination.

1995 ◽  
Vol 85 (11) ◽  
pp. 710-712
Author(s):  
G Smalls ◽  
M Alaie ◽  
M Anzilotti ◽  
M Lebwohl

The similarity in the skin manifestations in Henoch-Schönlein purpura as compared with systemic lupus erythematosus and rheumatoid arthritis complicates diagnosis. Therefore, analysis of hematologic studies, tissue histology, and immunofluorescence should be thoroughly reviewed.


2019 ◽  
Author(s):  
VALDIRENE SILVA SIQUEIRA ◽  
LORENA ELIZABETH BETANCOURT ◽  
ERIVELTON AZEVEDO LOPES ◽  
FERNANDO HENRIQUE CARLOS SOUZA ◽  
SAMUEL KATSUYUKI SHINJO

2021 ◽  
Author(s):  
Bruna Lindoso Correia ◽  
Rafael Giovani Misse ◽  
Alexandre Moura dos Santos ◽  
Isabela Bruna Pires Borges ◽  
Samuel Katsuyuki Shinjo

2021 ◽  
Vol 79 (2) ◽  
pp. 155-158
Author(s):  
Cleide Garbelini-Lima ◽  
Gabriela Evangelista de Almeida ◽  
Sidharta Quércia Gabdelha ◽  
Andrea Cavalcante de Souza ◽  
Mara Lúcia Gomes de Souza ◽  
...  

Scalp involvement with hair loss is common in systemic lupus erythematosus. Discoid lupus erythematosus may cause scarring alopecia, characterized by well-delimited erythematous plaques with scales, follicular hyperkeratosis and atrophy, which is considered a trichological emergency. Early diagnosis and treatment are necessary in order to prevent permanent hair loss. We describe a 44 years’ old female patient with systemic lupus erythematosus for 4 years, with multiple areas of occipitoparietal alopecia, erythematous plaques, atrophy, scales and some bloody crusts. Trichoscopy, histopathology and direct immunofluorescence led to the diagnosis of discoid lupus erythematosus. After 9 months treatment with thalidomide there was complete hair regrowth.


2015 ◽  
Vol 2015 ◽  
pp. 1-4 ◽  
Author(s):  
Guido Granata ◽  
Dario Didona ◽  
Giuseppina Stifano ◽  
Aldo Feola ◽  
Massimo Granata

Macrophage activation syndrome (MAS) is a potentially fatal condition. It belongs to the hemophagocytic lymphohistiocytosis group of diseases. In adults, MAS is rarely associated with systemic lupus erythematosus, but it also arises as complication of several systemic autoimmune disorders, like ankylosing spondylitis, rheumatoid arthritis, and adult-onset Still’s disease. Several treatment options for MAS have been reported in the literature, including a therapeutic regimen of etoposide, dexamethasone, and cyclosporine. Here we report a case of 42-year-old woman in whom MAS occurred as onset of systemic lupus erythematosus.


2021 ◽  
Vol 93 (5) ◽  
Author(s):  
Nadezhda L. Ryabkova ◽  
Irina M. Marusenko ◽  
Vadim A. Ryabkov

The article presents the case of the diagnosis of sepsis as a variant of a comorbid infection in a patient with cross syndrome (systemic lupus erythematosus and rheumatoid arthritis) on the background of the debut of coronary heart disease (acute myocardial infarction complicated by external rupture of the heart).


2021 ◽  
Author(s):  
Maria Eugênia Teixeira Bicalho ◽  
Carolina Teixeira Cidon ◽  
Thais Helena Bonini Gorayeb ◽  
Jucier Gonçalves Junior ◽  
Samuel Katsuyuki Shinjo

2020 ◽  
Vol 2020 ◽  
pp. 1-4 ◽  
Author(s):  
Wendlassida Joëlle Stéphanie Tiendrébéogo ◽  
Fulgence Kaboré ◽  
Eric Arnaud Diendéré ◽  
Dieu-Donné Ouedraogo

Coronavirus disease 2019 (COVID-19) is a viral infection that appeared in December 2019. The risk of infection seems to be increased in chronic inflammatory rheumatic diseases due to both immune disturbances related to the disease and treatment. In this case report, we describe the clinical features of 5 rheumatic immune disease patients with the concomitant presence of COVID-19. Among these patients, 3 had rheumatoid arthritis and 2 had systemic lupus erythematosus. Patients’ age ranged between 38 and 63 years. Only one patient (SLE) had a severe subtype of COVID-19. All the patients were cured of COVID-19 and were subsequently discharged.


2019 ◽  
Author(s):  
Nadia Ghariani Fetoui ◽  
Rima Gammoudi ◽  
Najet Ghariani ◽  
Yosra Hasni ◽  
Racha Fekih ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document